Ivax Pharmaceuticals (UK) Ltd v Astrazeneca AB [2004] EWHC 1264 (Ch) (28 May 2004)

Ivax Pharmaceuticals (UK) Ltd v Astrazeneca AB [2004] EWHC 1264 (Ch) (28 May 2004)

The presumption in favour of a stay was not rebutted by Ivax, as it failed to demonstrate sufficient commercial urgency or public interest to justify proceeding in parallel with the EPO. The potential prejudice to AstraZeneca regarding amendments and inconsistent decisions outweighed Ivax's arguments. The justice of the case did not require the English proceedings to continue.

Citation
[2004] EWHC 1264 (Ch)
Parties
Claimant: Ivax Pharmaceuticals (UK) Ltd; Defendant: AstraZeneca AB
Jurisdiction
England and Wales
Judgment Date
28 May 2004
Procedural Posture
Patent Revocation Action / Interlocutory Application for Stay of Proceedings
Outcome
Stay granted
Legal Topics
Stay of Proceedings, Parallel EPO Opposition, Patent Revocation, Obviousness, Jurisdictional Overlap

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 2 Authorities cited 4 Party arguments 2 Amounts and remedies 1
Sign in to unlock

Parties

Ivax Pharmaceuticals (UK) Ltd

Claimant

AstraZeneca AB

Defendant

Procedural Posture

Patent Revocation Action / Interlocutory Application for Stay of Proceedings

  1. 1 Whether English patent revocation proceedings should be stayed pending EPO opposition outcomes
  2. 2 Whether justice requires refusal of a stay due to commercial prejudice or public interest

Ratio Decidendi

The presumption in favour of a stay was not rebutted by Ivax, as it failed to demonstrate sufficient commercial urgency or public interest to justify proceeding in parallel with the EPO. The potential prejudice to AstraZeneca regarding amendments and inconsistent decisions outweighed Ivax's arguments. The justice of the case did not require the English proceedings to continue.

Court Disposition

Stay granted

Orders

  • Proceedings stayed pending determination of the parallel EPO opposition proceedings
  • Liberty to apply to remove the stay if circumstances change, particularly if the EPO proceedings are not prosecuted with due diligence